Danaher Corporation First Quarter 2024 Earnings Release ...

Danaher Corporation (NYSE:DHR) Q1 2024 Earnings Conference Call April 23, 2024 8:00 AM ET Company Participants John Bedford - VP of IR Rainer Blair - President & CEO Matthew McGrew - EVP & CFO Conference Call Participants Jack Meehan - Nephron Research Michael Ryskin - Bank of America Scott Davis - Melius Research Vijay Kumar - Evercore ISI Douglas Schenkel - Wolfe Research Daniel Leonard - UBS Rachel Vatnsdal - JPMorgan Operator Hello. My name is Todd, and I will be your conference facilitator this morning ...

Core Insights - Danaher reported revenue of $5.8 billion for Q1 2024, a decrease of 19.1% year-over-year, with EPS at $1.92 compared to $2.36 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $5.64 billion by 2.85%, and the EPS also surpassed the consensus estimate of $1.72 by 11.63% [1] Financial Performance Metrics - Organic sales growth was -4%, better than the estimated -6.9% [2] - Diagnostics sales reached $2.53 billion, exceeding the average estimate of $2.43 billion, reflecting a year-over-year increase of 6.4% [2] - Life Sciences sales were $1.75 billion, slightly above the estimated $1.72 billion, marking a 2.1% year-over-year increase [2] - Biotechnology sales totaled $1.52 billion, surpassing the average estimate of $1.49 billion [2] - Operating profit for Life Sciences was $235 million, below the estimated $288.47 million [2] - Operating profit for Biotechnology was $325 million, also below the estimated $350.46 million [2] - Operating profit for Diagnostics was $830 million, significantly above the average estimate of $651.02 million [2] - The "Other" segment reported an operating loss of $78 million, worse than the estimated loss of $71.44 million [2] Stock Performance - Danaher's shares have returned -4.7% over the past month, compared to a -4.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Danaher (DHR) came out with quarterly earnings of $1.92 per share, beating the Zacks Consensus Estimate of $1.72 per share. This compares to earnings of $2.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 11.63%. A quarter ago, it was expected that this industrial and medical device maker would post earnings of $1.90 per share when it actually produced earnings of $2.09, delivering a surprise of 10%.Over the last four quarte ...

Exhibit 99.1 Innovation at the speed of life Danaher Reports First Quarter 2024 Results WASHINGTON D.C., April 23, 2024 -- Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended March 29, 2024. All results in this release reflect only continuing operations unless otherwise noted. Key First Quarter 2024 Results • Net earnings were $1.1 billion, or $1.45 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $1.92. • Revenues decreased ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Danaher (DHR) , which belongs to the Zacks Diversified Operations industry.When looking at the last two reports, this industrial and medical device maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 10.19%, on average, in the last two quarters.For the last reported quarter, Danaher came out with earnings o ...

Danaher Corporation (DHR) is scheduled to release first-quarter 2024 results on Apr 23, before market open.The company’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 6.8%. In the last reported quarter, its earnings of $2.09 per share beat the consensus estimate of $1.90 by 10%.Let’s see how things have shaped up for Danaher this earnings season.Key Factors and Estimates for Q1Improving supply chains and strong price realization are expecte ...

Wall Street analysts forecast that Danaher (DHR) will report quarterly earnings of $1.72 per share in its upcoming release, pointing to a year-over-year decline of 27.1%. It is anticipated that revenues will amount to $5.64 billion, exhibiting a decline of 21.3% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 0.5% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimat ...

Danaher Corporation (DHR) is well poised for growth courtesy of strength across its end markets, strategic acquisitions and its focus on improving the product line and operational excellence.Image Source: Zacks Investment ResearchThe company has a market capitalization of $180.7 billion. In the past six months, the stock has gained 16.5% compared with the industry’s growth of 5.4%. DHR currently carries a Zacks Rank #2 (Buy).Let’s delve into the factors that have been aiding the firm for a while now.Busines ...

Company Performance - Danaher (DHR) ended the recent trading session at $244.28, showing a +0.98% change from the previous day's closing price, which lagged behind the S&P 500's daily gain of 1.11% [1] - Over the last month, Danaher's shares have decreased by 4.81%, underperforming the Conglomerates sector's loss of 4.23% and the S&P 500's gain of 0.48% [1] - The upcoming earnings release on April 23, 2024, is anticipated to show an EPS of $1.72, reflecting a 27.12% decline compared to the same quarter last year, with expected revenue of $5.64 billion, indicating a 21.31% drop year-over-year [1] Earnings Estimates - The full-year Zacks Consensus Estimates for Danaher project earnings of $7.62 per share and revenue of $24.09 billion, representing year-over-year changes of +0.53% and -12.73%, respectively [2] - Recent changes to analyst estimates for Danaher are important as they indicate shifts in near-term business trends, with positive revisions suggesting optimism about the company's outlook [2] Valuation Metrics - Danaher currently holds a Forward P/E ratio of 31.73, which is a premium compared to the industry average Forward P/E of 18.22 [3] - The PEG ratio for Danaher is 3.68, significantly higher than the industry average PEG ratio of 1.81, indicating a higher valuation relative to expected earnings growth [3] Industry Context - The Diversified Operations industry, part of the Conglomerates sector, has a Zacks Industry Rank of 20, placing it in the top 8% of over 250 industries [4] - The Zacks Industry Rank assesses the strength of industry groups, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [4]